2025-05-12 - Analysis Report
Okay, here's a report based on the data you provided, presented with key numbers first, followed by analysis.

**Colgate-Palmolive Co (CL) Stock Analysis**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** CL
*   **Company Overview:** Colgate-Palmolive is a global consumer products company focused on oral care, personal care, home care, and pet nutrition.
*   **CL Cumulative Return:** 34.14%
*   **VOO Cumulative Return:** 87.98%
*   **Absolute Divergence (CL - VOO):** -53.84%
*   **Relative Divergence:** 17.3%

**Analysis of Performance Table:**

| Year      | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :---------- | :------ | :------ | :------ | :---- | :------ |
| 2015-2017 | 16.0%   | 4.2%    | -16.0%  | 0.1   | 50.6   |
| 2016-2018 | -9.0%   | 65.3%   | -30.0%  | 0.1   | 40.9   |
| 2017-2019 | 10.0%   | 65.3%   | -24.0%  | -0.3  | 48.5   |
| 2018-2020 | 22.0%   | 65.3%   | -8.0%   | 0.3   | 61.7   |
| 2019-2021 | 34.0%   | 58.5%   | -26.0%  | 0.8   | 63.0   |
| 2020-2022 | 11.0%   | 68.9%   | 2.0%    | 0.7   | 59.5   |
| 2021-2023 | 8.0%    | 68.9%   | -13.0%  | 0.6   | 61.8   |
| 2022-2024 | 16.0%   | 68.9%   | -5.0%   | 0.5   | 72.0   |
| 2023-2025 | 11.0%   | 73.0%   | -15.0%  | 0.2   | 72.8   |

*   **Divergence:** CL has significantly underperformed the S&P 500 over the period.  The negative absolute divergence (-53.84%) confirms this. The Relative Divergence of 17.3% suggests that the current underperformance is closer to the historical minimum divergence, indicating it might be near its worst relative position compared to the S&P 500 within the observed range.
*   **Alpha:** The Alpha is generally negative, indicating the stock has underperformed relative to its risk-adjusted expected return based on the market.  There's only one period (2020-2022) where Alpha is positive.
*   **Beta:** Beta values are generally low, suggesting CL is less volatile than the market.
*   **Maximum Drawdown (MDD):** MDD figures are relatively high in recent periods, suggesting significant potential losses from peak to trough.
*   **CAGR:** The Compound Annual Growth Rate fluctuates, with some periods showing negative growth.
*   **Cap:** Market capitalization generally increased over the observed periods.

**2. Recent Price Action**

*   **Current Price:** 90.83
*   **Last Market Data:**
    *   Price: 89.81
    *   Previous Close: 90.83
    *   Change: -1.12
*   **5-Day Moving Average:** 90.79
*   **20-Day Moving Average:** 92.63
*   **60-Day Moving Average:** 91.21

**Analysis:**

*   The recent price of \$89.81 is below both the previous close (\$90.83), the 5-day moving average, the 20-day moving average, and the 60-day moving average, suggesting a short-term downward trend.
*   The price is below all moving averages, indicating potential bearish momentum.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3707 (Low Risk)
*   **RSI:** 32.16 (Approaching Oversold)
*   **PPO:** -0.37
*   **Recent (20-day) Relative Divergence Change:** -2.8 (Short-term decrease)
*   **Expected Return:** -180.1%

**Analysis:**

*   **MRI:** The MRI suggests a low-risk environment for the overall market.
*   **RSI:** An RSI of 32.16 indicates the stock is nearing oversold territory, potentially signaling a possible upcoming reversal.
*   **PPO:** A negative PPO indicates that the short-term moving average is below the long-term moving average, confirming the downward trend.
*   **Relative Divergence Change:** A negative change in relative divergence supports the short-term downward trend, implying CL is underperforming the S&P 500.
*   **Expected Return:** The extremely negative expected return suggests that, under the model's assumptions, CL is projected to significantly underperform the S&P 500 over the long term.  This should be interpreted with caution, as these models are sensitive to input parameters.
*   **Last Market Data:** The recent price change of -1.12 indicates a slightly more pronounced recent downtick, potentially amplifying existing bearish signals.

**4. Recent News & Significant Events**

*   **2025-05-10:** Major business developments, regulatory changes, or market events.
*   **2025-05-12:** Analyst discussions about performance, industry trends, and global economic factors.
*   **2025-05-09:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-05-11:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news snippets suggest increased volatility and potential uncertainty surrounding Colgate-Palmolive. Investors should closely monitor upcoming news and company announcements to assess the situation.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
| :----------- | :--- | :-------- |
| 2025-04-25 | 0.85 | 4.91 B\$  |
| 2024-10-25 | 0.9  | 5.03 B\$  |
| 2024-07-26 | 0.89 | 5.06 B\$  |
| 2024-04-26 | 0.83 | 5.07 B\$  |
| 2025-04-25 | 0.83 | 5.07 B\$  |

**Analysis:**

*   Revenue shows a slight downward trend over the past several quarters.
*   EPS is relatively stable but also shows some variability.
*   Latest EPS:0.83 and Revenue: 5.07 B\$ the same values as in 2024-04-26.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31 | \$4.91B   | 60.82%        |
| 2024-12-31 | \$4.95B   | 60.30%        |
| 2024-09-30 | \$5.03B   | 61.08%        |
| 2024-06-30 | \$5.06B   | 60.62%        |
| 2024-03-31 | \$5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| :----------- | :-------- | :-------- |
| 2025-03-31 | \$0.36B   | 190.08%   |
| 2024-12-31 | \$0.21B   | 348.58%   |
| 2024-09-30 | \$0.43B   | 169.43%   |
| 2024-06-30 | \$0.12B   | 594.31%   |
| 2024-03-31 | \$0.23B   | 296.96%   |

**Analysis:**

*   **Revenue:**  Similar to the earnings data, revenue has generally decreased over the past five quarters.
*   **Profit Margin:** Profit margins are relatively stable, consistently above 60%.
*   **Equity:** Equity fluctuates significantly.
*   **ROE:** Return on Equity is highly variable and extremely high, which could be due to low equity values. Extremely high ROE values can sometimes indicate accounting anomalies or unsustainable conditions.

**7. Overall Summary**

*   **Underperformance:** CL has significantly underperformed the S&P 500 over the analyzed period.
*   **Downward Momentum:** Recent price action, technical indicators (RSI, PPO), and the change in relative divergence suggest short-term downward momentum.
*   **Stable Profitability:** Profit margins remain strong, but revenue shows a slight downtrend.
*   **High Volatility & Uncertainty:** Recent news suggests increased market sensitivity and potential risks/opportunities.
*   **Concerning ROE:** The extremely high and fluctuating ROE values warrant further investigation. This may be due to low equity values and may not be sustainable.
*   **Negative Long-Term Outlook:** The extremely negative expected return is a significant concern, although model assumptions should be considered.
*   **Low Risk Market:** Overall market risk is currently assessed as low.

**Conclusion:**

Based on this analysis, CL is currently facing challenges. The underperformance compared to the S&P 500, recent downward price trends, and concerning financial metrics (especially ROE and expected return) warrant caution. While the company maintains strong profitability, declining revenue and market volatility suggest potential headwinds. Investors should carefully monitor upcoming news and company announcements and conduct further due diligence before making investment decisions.
